Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Ovarian Neoplasms |
Free Subscription
1 BMC Cancer |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Ovarian Neoplasms is free of charge.
A novel TCGA-validated programmed cell-death-related signature of ovarian cancer.
BMC Cancer. 2024;24:515.
PubMed
Abstract available
Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic
profiling.
Br J Cancer. 2024 Apr 24. doi: 10.1038/s41416-024-02644.
PubMed
Abstract available
Exploring the effect of BRCA1/2 status on chemotherapy-induced hematologic
toxicity in patients with ovarian cancer.
Cancer Chemother Pharmacol. 2024 Apr 23. doi: 10.1007/s00280-024-04670.
PubMed
Abstract available
Deciphering a GPCR-lncRNA-miRNA Nexus: Identification of an Aberrant Therapeutic
Target in Ovarian Cancer.
Cancer Lett. 2024 Apr 18:216891. doi: 10.1016/j.canlet.2024.216891.
PubMed
Abstract available
Eur J Obstet Gynecol Reprod Biol
Evaluation of serum CA125, HE4 and CA724 and the risk of ovarian malignancy
algorithm score in the diagnosis of high-grade serous ovarian cancer.
Eur J Obstet Gynecol Reprod Biol. 2024;297:170-175.
PubMed
Abstract available
Editorial: Infiltrative pattern of invasion is independently associated with
shorter survival and desmoplastic stroma markers FAP and THBS2 in mucinous
ovarian carcinoma.
Histopathology. 2024;84:1092-1094.
PubMed
Infiltrative pattern of invasion is independently associated with shorter
survival and desmoplastic stroma markers FAP and THBS2 in mucinous ovarian
carcinoma.
Histopathology. 2024;84:1095-1110.
PubMed
Abstract available
PReferentially Expressed Antigen in MElanoma Expression in Uterine and Ovarian
Carcinosarcomas.
Int J Gynecol Pathol. 2024;43:284-289.
PubMed
Abstract available
Ovarian Mesonephric-like Adenocarcinoma Recurring With a Rhabdomyosarcoma
Component: A Case Report.
Int J Gynecol Pathol. 2024;43:296-301.
PubMed
Abstract available
Endometrioid Adenocarcinoma With "Burrowing" Invasion of the Cervix Represents a
Separate Primary From the Concurrent Uterine Corpus Endometrial Endometrioid
Adenocarcinoma: Histology, Immunohistochemistry, and Next-generation Sequencing
Study of a Si
Int J Gynecol Pathol. 2024;43:271-274.
PubMed
Abstract available
Divergent Malignant Melanocytic Differentiation in Ovarian Endometrioid
Adenocarcinoma With Aberrant beta-Catenin Expression: A Case Expanding the
Histologic Spectrum of beta-Catenin Activated Gynecologic Neoplasia.
Int J Gynecol Pathol. 2024;43:302-307.
PubMed
Abstract available
Molecular Classification of Endometrial Endometrioid Carcinoma With Microcystic
Elongated and Fragmented Pattern.
Int J Gynecol Pathol. 2024;43:233-241.
PubMed
Abstract available
Comprehensive Immunohistochemical Analysis of Mesonephric Marker Expression in
Low-grade Endometrial Endometrioid Carcinoma.
Int J Gynecol Pathol. 2024;43:221-232.
PubMed
Abstract available
Diagnosis Shift in Site of Origin of Tubo-Ovarian Carcinoma.
Obstet Gynecol. 2024 Mar 21. doi: 10.1097/AOG.0000000000005562.
PubMed
Abstract available
GSK3beta and UCHL3 govern RIPK4 homeostasis via deubiquitination to enhance tumor
metastasis in ovarian cancer.
Oncogene. 2024 Apr 25. doi: 10.1038/s41388-024-03040.
PubMed
Abstract available
Beyond BRCA: Diagnosis and management of homologous recombination repair
deficient pancreatic cancer.
Semin Oncol. 2024;51.
PubMed
Abstract available
PARP inhibitors: A review of the pharmacology, pharmacokinetics, and
pharmacogenetics.
Semin Oncol. 2024;51.
PubMed
Abstract available
Thank you for your interest in scientific medicine.